Compugen Ltd.
CGEN
$2.24
$0.031.36%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 4,477.29% | -81.24% | -95.60% | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 4,477.29% | -81.24% | -95.60% | -- | |
| Cost of Revenue | 423.85% | 7.28% | -66.32% | -- | |
| Gross Profit | 7,914.57% | -107.92% | -97.47% | -- | |
| SG&A Expenses | -6.67% | 0.04% | -6.88% | 19.17% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 26.08% | -4.23% | -42.14% | 18.89% | |
| Operating Income | 848.94% | -147.04% | -141.61% | 142.30% | |
| Income Before Tax | 1,029.90% | -248.44% | -132.66% | 158.67% | |
| Income Tax Expenses | -100.00% | -254.55% | -99.96% | -- | |
| Earnings from Continuing Operations | 1,029.30% | -245.83% | -162.98% | 112.95% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 1,029.30% | -245.83% | -162.98% | 112.95% | |
| EBIT | 848.94% | -147.04% | -141.61% | 142.30% | |
| EBITDA | 862.91% | -152.40% | -140.66% | 143.92% | |
| EPS Basic | 982.58% | -231.22% | -162.15% | 112.81% | |
| Normalized Basic EPS | 780.15% | -234.69% | -142.10% | -- | |
| EPS Diluted | 961.14% | -231.22% | -163.69% | 112.81% | |
| Normalized Diluted EPS | 780.15% | -234.69% | -142.10% | -- | |
| Average Basic Shares Outstanding | 5.32% | 4.46% | 1.27% | 1.39% | |
| Average Diluted Shares Outstanding | 5.32% | 4.46% | 1.27% | 1.39% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |